In a busy week of Big Phama results Pfizer reports sales boost from Wyeth, Roche says Genentech hit profits and GSK unveils surge in Relenza sales and plans to expand R&D restructuring.
Wyeth Pharmaceuticals is continuing efforts to improve its capabilities in the formulation and delivery of RNA through a strategic partnership with Santaris Pharma.
Akrimax Pharmaceuticals, which entered the contract manufacturing sector via the purchase of a Wyeth facility in New York, US, a year ago - has signed its first third-party agreement.
A Californian appeals court ruling may have altered product liability in the state, which could lead to numerous court cases being brought against big pharma.
1200 sales representatives are the latest casualties of Wyeth's
recently announced cost cutting drive, which strives to eliminate
10 per cent of the work force - 5,000 jobs - over the next three
years.
Wyeth Pharmaceuticals is expanding its research into small
molecules schizophrenia drugs and biopharmaceuticals to treat
haemophilia, having announced three deals in a day earlier this
week.
US Food and Drug Administration (FDA) has until April 2007 to reply
to a Citizen's Petition (CP) filed by Orchid Chemicals in response
to accusations of 'evergreening' related to Wyeth's re-formulated
Zosyn (piperacillin/tazobactam),...
Shipping giant DHL has bagged a lucrative contract with pharma
giant Wyeth and become the first logistics provider to be given
complete responsibility for a company's worldwide clinical trial
materials distribution.
Wyeth has boosted production at the US plant it has earmarked for
closure while it is dealing with ongoing manufacturing deficiencies
in its Puerto Rico facility.
Wyeth Pharmaceuticals has announced they have entered into
collaboration with Ablynx in a deal, which aims to commercialise a
class of antibody-derived therapeutic proteins targeting diseases
that include oncology and Alzheimer's...
Genedata has formed a new collaboration with Wyeth Pharma in which
the computational biology firm will lend its support to Wyeth's
drug discovery efforts.
With its manufacturing practices in Puerto Rico censured and
marketing approval of its new oral contraceptive delayed because of
its packaging, Wyeth has announced a plan to address its
manufacturing issues but cautions there is no...
Despite the uncertainty about its direction, German pharmaceutical
company Altana has opened a new tablet production facility in Cork
as it tries to cope with demand for Pantoprazole, its blockbuster
stomach ulcer drug.
In a scathing letter to Wyeth, the US Food and Drug Administration
(FDA) has vehemently criticised the drugmaker's manufacturing
operations in Puerto Rico, accusing it of failing to report
failures even when it was aware of them.
Pharmaceutical manufacturers, Wyeth, are to phase out manufacturing
at its US facility as part of its consolidation plans, which will
see the gradual phasing out of all operations at the New York
facility by late 2008.
Wyeth yesterday formally opened its Grange Castle biotech
production facility in South County Dublin, Ireland, one of the
largest integrated biotech manufacturing facilities in the world.
Dublin City University in Ireland and pharmaceutical major Wyeth
have started a four-year research collaboration aimed at improving
the production of biopharmaceuticals, reports Phil Taylor.
